Cargando…
Effects of Different Anticoagulation Doses on Moderate-to-Severe COVID-19 Pneumonia With Hypoxemia
Background COVID-19 is a prothrombotic disease that can cause thromboembolism and microthrombi, which could lead to multiorgan failure and death. Since COVID-19 is a relatively new disease, there are guidelines for anticoagulation dosing for COVID-19 patients without consensus on the dosing. We stud...
Autores principales: | Nadeem, Amin Ur Rehman, Naqvi, Syed M, Chandy, Kurian G, Nagineni, Venkata V, Nadeem, Rashid, Desai, Shreya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495222/ https://www.ncbi.nlm.nih.gov/pubmed/37700943 http://dx.doi.org/10.7759/cureus.43389 |
Ejemplares similares
-
Leukocytosis and Spurious Hypoxemia
por: Gupta, Sachin, et al.
Publicado: (2021) -
High-Dose Prophylactic Anticoagulation in Severe COVID-19 Pneumonia
por: Nadeem, Rashid, et al.
Publicado: (2021) -
Topical Anesthetics and Premature Ejaculation: A Systematic Review and Meta-Analysis
por: Shah, M Danial Ali, et al.
Publicado: (2023) -
A Case Report of Cyanosis With Refractory Hypoxemia: Is It Methemoglobinemia?
por: Kamath, Sangita D, et al.
Publicado: (2022) -
Comparative Efficacy of Direct Oral Anticoagulants and Low-Molecular-Weight Heparin in Cancer-Associated Thromboembolism: A Systematic Review and Meta-Analysis
por: Patel, Tirath, et al.
Publicado: (2023)